Browse Industries For Buyers For Sellers Sign in Get started free

Highly fragmented · Approximately $8–10 billion U.S. market including laboratory testing, collection services, and MRO review

Acquire a Drug Testing Services
Business

Q: What EBITDA multiple do Drug Testing Services businesses sell for?

Drug Testing Services businesses typically sell for 3.5–6× EBITDA in the lower middle market ($1M–$5M revenue). Highly fragmented market with growing demand.

Q: How do I buy a Drug Testing Services business with an SBA loan?

Yes, Drug Testing Services businesses are SBA 7(a) eligible. SBA 7(a) loan financing with 10–15% buyer equity injection, seller note of 5–10% held for 24 months, and earnout tied to client retention post-close

Q: What should I look for when buying a Drug Testing Services business?

Key due diligence areas for Drug Testing Services acquisitions include: Regulatory compliance history including DOT, SAMHSA, and state occupational health licensing audits and any citations or consent orders; Client contract terms, renewal rates, and concentration analysis across employer, government, and court-ordered testing segments; Lab and MRO vendor agreements including pricing, exclusivity, and termination clauses; Revenue mix between collection fees, MRO services, and pass-through lab charges to isolate true margin; Technology infrastructure including LIMS, chain-of-custody software, and integration capability with HR/payroll platforms.

Drug testing services provide employer-mandated and court-ordered specimen collection, laboratory analysis, and Medical Review Officer services to ensure workforce compliance with federal DOT regulations and state drug-free workplace programs. The industry serves a broad range of end markets including transportation, healthcare, construction, and government, with demand anchored by non-discretionary regulatory requirements. Consolidation is accelerating as national occupational health platforms and background screening companies acquire regional collection networks to offer bundled compliance solutions.

Who buys these: Private equity-backed roll-up platforms, strategic acquirers such as occupational health companies and laboratory networks, entrepreneurial buyers with healthcare or HR backgrounds, and independent sponsors seeking essential B2B service businesses

3.5–6×

Typical EBITDA multiple

$1M–$5M

Revenue range

Growing

Market trend

SBA Eligible

7(a) financing available

Recession Resistant

Essential service

Find Active Drug Testing Services Businesses For Sale Selling instead? →

Typical Acquisition Criteria

Established businesses with $500K–$5M EBITDA, recurring employer contract base, DOT-authorized collector certification, SAMHSA-certified lab relationships, clean regulatory history, and diversified client roster with no single account exceeding 20% of revenue

Get Deal Flow In Your Inbox

New Drug Testing Services acquisition targets delivered weekly — free to join.

Join Free

Buyer Pain Points

1Difficulty assessing revenue concentration risk when a few large employer accounts drive the majority of collections volume
2Uncertainty around regulatory compliance with DOT, SAMHSA, and state-specific drug testing mandates
3Challenges evaluating the durability of third-party administrator (MRO) and lab partnerships and associated margin compression
4Concerns about technology obsolescence as oral fluid and rapid testing devices displace traditional urine specimen collection models
5Limited visibility into employee and owner dependency, particularly when the seller performs MRO reviews or manages key corporate accounts personally

Common Deal Structures

1SBA 7(a) loan financing with 10–15% buyer equity injection, seller note of 5–10% held for 24 months, and earnout tied to client retention post-close
2Asset purchase with allocated consideration across goodwill, client lists, and equipment, including 12–24 month transition and non-compete agreement
3Equity rollover deal where seller retains 10–20% minority stake to participate in platform growth under PE-backed roll-up

Due Diligence Focus Areas

Key items to investigate when evaluating a Drug Testing Services acquisition

Regulatory compliance history including DOT, SAMHSA, and state occupational health licensing audits and any citations or consent orders
Client contract terms, renewal rates, and concentration analysis across employer, government, and court-ordered testing segments
Lab and MRO vendor agreements including pricing, exclusivity, and termination clauses
Revenue mix between collection fees, MRO services, and pass-through lab charges to isolate true margin
Technology infrastructure including LIMS, chain-of-custody software, and integration capability with HR/payroll platforms

Competitive Moats

DOT consortium management and MRO services create high switching costs and recurring revenue that lock in employer clients long-term
Local collection site density and mobile collection fleet capability serve industries where proximity and rapid response are operationally critical
Deep compliance expertise and trusted regulatory relationships with employers provide a meaningful barrier to entry for generalist healthcare or HR competitors

Key Industry Risks

⚠Regulatory shifts such as marijuana legalization reducing employer willingness to test for cannabis, compressing testing volumes in non-DOT segments
⚠Margin compression from national laboratory networks and large third-party administrators disintermediating independent collection operators
⚠Technology disruption from oral fluid, hair follicle, and point-of-care rapid testing devices reducing reliance on traditional collection site infrastructure

Seller Intelligence

Who sells Drug Testing Services businesses?

Owner-operators of independent drug testing collection networks, occupational health clinic operators offering drug testing as a core service, and founders of employer compliance programs who built businesses serving transportation, construction, healthcare, and government sectors

Typical exit timeline: 12–18 months

Seller page

Frequently Asked Questions

How much does a Drug Testing Services business cost?

Drug Testing Services businesses in the $1M–$5M revenue range typically sell for 3.5–6× EBITDA. Established businesses with $500K–$5M EBITDA, recurring employer contract base, DOT-authorized collector certification, SAMHSA-certified lab relationships, clean regulatory history, and diversified client roster with no single account exceeding 20% of revenue

What EBITDA multiple do Drug Testing Services businesses sell for?

Drug Testing Services businesses typically trade at 3.5–6× EBITDA in the lower middle market. The market is highly fragmented with growing demand, which supports premium multiples.

How do I buy a Drug Testing Services business with an SBA loan?

Drug Testing Services businesses are SBA 7(a) eligible, making them accessible to first-time buyers. SBA 7(a) loan financing with 10–15% buyer equity injection, seller note of 5–10% held for 24 months, and earnout tied to client retention post-close

What should I look for when buying a Drug Testing Services business?

Key due diligence areas include: Regulatory compliance history including DOT, SAMHSA, and state occupational health licensing audits and any citations or consent orders; Client contract terms, renewal rates, and concentration analysis across employer, government, and court-ordered testing segments; Lab and MRO vendor agreements including pricing, exclusivity, and termination clauses; Revenue mix between collection fees, MRO services, and pass-through lab charges to isolate true margin; Technology infrastructure including LIMS, chain-of-custody software, and integration capability with HR/payroll platforms.

Related Industries to Acquire

Pain Management Clinic →Transmission Repair Shop →Mexican Restaurant →Drain Cleaning & Hydro Jetting →DJ & Entertainment Services →Browse all 30 industries →

Start Finding Drug Testing Services Deals Today — Free to Join

DealFlow OS surfaces acquisition targets, scores seller motivation, and generates outreach — all in one place.

Start finding deals — free

No credit card required

Acquire a Drug Testing ServicesBusiness